Related Experiment Video
Updated: Feb 21, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Medication Adherence Using Medication Event Monitoring System Among Young Adults with Major Depressive Disorder
Jia Xu1, Weiwei Zhao1, Pan Lin1
1Department of Psychiatry, the Affiliated Brain Hospital of Nanjing Medical University, Nanjing City, Jiangsu Province, China.
Abstract:
To investigate factors associated with medication adherence among young patients experiencing their first episode of major depressive disorder (MDD). A total of 512 patients were prospectively enrolled and tracked by adherence for 30 days using the Medication Event Monitoring System (MEMS). Socio-demographic factors, clinical variables, and patient-reported rating scores were analyzed using a binary logistic regression model. About 69.3% of cases achieved MEMS adherence. Patients with ≥1 hospital readmission for exacerbation, drug concentration beyond the recommended therapeutic range, and severe side effects had an increased risk of low adherence. Older age, higher self-stigma scores, and negative drug attitude were the positive predictors. A prognostic index > 0.800 was at high-risk of developing low adherence. A formula was established for evaluating clinical risk to improve medication adherence among young MDDs.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Drug Therapy
Antianxiety Medications
Therapeutic Drug Monitoring: Affecting Factors
Depressive Disorders: MDD and Dysthymia
Antidepressant Drugs: Overview
Therapeutic Drug Monitoring: Overview and Classification

